Pierre Beauparlant

2.0k citations
25 papers · 1.6k indexed · 1 hit paper · h-index 16
Topics
NF-κB Signaling Pathways (9 papers)Immune Response and Inflammation (6 papers)interferon and immune responses (4 papers)
Partner nations
CanadaAustraliaSpain

In The Last Decade

Pierre Beauparlant

24 papers receiving 1.5k citations

Hit Papers

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and...20072026201320192007100200300400500

Peers

Pierre Beauparlant
Comparison fields: 5 of 87
  • Molecular Biology 874
  • Immunology 495
  • Cancer Research 394
  • Oncology 329
  • Epidemiology 196
Replace R. Michael Sramkoski with:
R. Michael Sramkoski United States
Fabienne Aillet Spain
İlker Dıbırdık United States
Ryusho Kariya Japan
Laëtitia K. Linares France
Hidekazu Nakabayashi Japan
Suresh Kumar United States
Ramesh B. Batchu United States
Matthias Germer Germany
James D. Bretz United States
Pierre Beauparlant relative to R. Michael Sramkoski United States R. Michael Sramkoski's profile →
Citations per field
00.5×1.5×2.0×
R. Michael Sramkoski · 1×
Citations per year

Countries citing papers authored by Pierre Beauparlant

Since Specialization
Citations

This map shows the geographic impact of Pierre Beauparlant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Beauparlant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Beauparlant more than expected).

Fields of papers citing papers by Pierre Beauparlant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Beauparlant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Beauparlant. The network helps show where Pierre Beauparlant may publish in the future.

Co-authorship network of co-authors of Pierre Beauparlant

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Beauparlant. A scholar is included among the top collaborators of Pierre Beauparlant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Beauparlant. Pierre Beauparlant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 51
2 1
3
GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase.
2
4 4
5 45
6 3
7 2
8 93
9
Therapeutic activation of caspases in cancer: a question of selectivity.
24
10 66
11 48
12 19
13 120
14 186
15 32
16
Retrovirus-mediated transfer of nuclear factor-kappa B subunit genes modulates I kappa B alpha and interferon beta expression.
8
17 44
18 1
19 42
20 1

About Pierre Beauparlant

Pierre Beauparlant is a scholar working on Virology, Cancer Research and Immunology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (9 papers), Immune Response and Inflammation (6 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Virology (150 citations), Cancer Research (394 citations) and Immunology (495 citations). Pierre Beauparlant has collaborated with scholars based in Canada, Australia and Spain. Frequent co-authors include John Hiscott, Rongtuan Lin, Anne Roulston, Gordon C. Shore, Mark A. Wainberg, Constantin Makris, Sylvain Meloche, Daniel Goulet, Laurent Bélec and Enrico O. Purisima. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026